ES2082746T3 - Nuevo sistema de expresion. - Google Patents

Nuevo sistema de expresion.

Info

Publication number
ES2082746T3
ES2082746T3 ES88101397T ES88101397T ES2082746T3 ES 2082746 T3 ES2082746 T3 ES 2082746T3 ES 88101397 T ES88101397 T ES 88101397T ES 88101397 T ES88101397 T ES 88101397T ES 2082746 T3 ES2082746 T3 ES 2082746T3
Authority
ES
Spain
Prior art keywords
hosts
preparation
recombinant dna
dna molecules
expression system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88101397T
Other languages
English (en)
Other versions
ES2082746T5 (es
Inventor
Jutta Dr Heim
Christof Dr Gysler
Jacob Prof Visser
Hermanus Cornelis Maria Kester
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10611694&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2082746(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2082746T3 publication Critical patent/ES2082746T3/es
Publication of ES2082746T5 publication Critical patent/ES2082746T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2408Glucanases acting on alpha -1,4-glucosidic bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/66Aspergillus
    • C12R2001/685Aspergillus niger

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Image Generation (AREA)
  • Complex Calculations (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Multi-Process Working Machines And Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hardware Redundancy (AREA)

Abstract

LA INVENCION SE REFIERE A MOLECULAS DE ADN RECOMBINANTE QUE CODIFICAN UN SISTEMA DE EXPRESION DE PECTINA-LIASA Y A SUS DERIVADOS TALES COMO EL GEN ESTRUCTURAL DE PLI Y LAS SECUENCIAS REGULADORAS CORRESPONDIENTES, POR EJEMPLO SECUENCIAS PROMOTORA, DE SEÑAL Y DE TERMINACION Y VECTORES HIBRIDOS QUE COMPRENDEN LOS ADN CORRESPONDIENTES, INCLUYENDO VECTORES HIBRIDOS CON ADN CODIFICADOR DE POLIPEPTIDOS HOMOLOGOS Y HETEROLOGOS, HUESPEDES, ESPECIALMENTE HONGOS FILAMENTOSOS, POR EJEMPLO HUESPEDES DE ASPERGILLUS, TRANSFORMADOS POR DICHOS VECTORE, METODOS PARA LA PREPARACION DE DICHAS MOLECULAS DE ADN RECOMBINANTE Y DICHOS HUESPEDES Y EL EMPLEO DE LAS MOLECULAS DE ADN RECOMBINANTE PARA LA PREPARACION DE NUEVOS SISTEMAS DE EXPRESION. UN NUEVO OBJETIVO ES LA PREPARACION DE POLIPEPTIDOS POR MEDIO DE DICHOS ADN Y DICHOS HUESPEDES.
ES88101397T 1987-02-04 1988-02-01 Nuevo sistema de expresion. Expired - Lifetime ES2082746T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878702475A GB8702475D0 (en) 1987-02-04 1987-02-04 Expression system

Publications (2)

Publication Number Publication Date
ES2082746T3 true ES2082746T3 (es) 1996-04-01
ES2082746T5 ES2082746T5 (es) 2003-06-16

Family

ID=10611694

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88101397T Expired - Lifetime ES2082746T5 (es) 1987-02-04 1988-02-01 Nuevo sistema de expresion.

Country Status (23)

Country Link
EP (2) EP0278355B2 (es)
JP (1) JP2633885B2 (es)
KR (1) KR970001116B1 (es)
AT (1) ATE133706T1 (es)
AU (1) AU625773B2 (es)
CA (1) CA1327330C (es)
DD (3) DD267511A5 (es)
DE (1) DE3854947T3 (es)
DK (1) DK175569B1 (es)
ES (1) ES2082746T5 (es)
FI (1) FI105484B (es)
GB (1) GB8702475D0 (es)
GR (1) GR3018863T3 (es)
HU (1) HU214005B (es)
IE (2) IE960902L (es)
IL (1) IL85293A (es)
MX (1) MX10286A (es)
NO (1) NO179078C (es)
NZ (1) NZ223392A (es)
PH (1) PH26106A (es)
PT (1) PT86684B (es)
YU (1) YU21688A (es)
ZA (1) ZA88757B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618920A (en) * 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
US5576195A (en) * 1985-11-01 1996-11-19 Xoma Corporation Vectors with pectate lyase signal sequence
US5447862A (en) * 1987-02-04 1995-09-05 Ciba-Geigy Corporation Pectin lyase genes of aspergillus niger
EP0396612B1 (en) * 1988-01-11 1996-07-24 Xoma Corporation Novel plasmid vector with pectate lyase signal sequence
AU627443B2 (en) * 1988-01-11 1992-08-27 Xoma Corporation Novel plasmid vector with pectate lyase signal sequence
ES2063162T5 (es) * 1988-07-28 2002-11-16 Novartis Ag Nuevo sistema de expresion.
EP0421919A3 (en) * 1989-09-02 1992-04-15 Ciba-Geigy Ag Polygalacturonase encoding fungal expression system
PL175670B1 (pl) * 1992-12-24 1999-01-29 Gist Brocades Nv Oczyszczona i wyizolowana sekwencja DNA kodująca polipeptyd wykazujący aktywność enzymu poligalakturonazy (PGX) z Aspergillus tubigensis
AU677296B2 (en) * 1993-02-16 1997-04-17 Novozymes A/S An enzyme with pectin lyase activity
US5674728A (en) * 1993-11-03 1997-10-07 Novartis Corporation Aspergillus niger vacuolar aspartyl protease
WO1997038123A1 (en) * 1996-04-05 1997-10-16 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
US6083715A (en) * 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
US6165769A (en) * 1997-11-24 2000-12-26 Novo Nordisk A/S Pectin degrading enzymes from Bacillus licheniformis
WO1999027083A1 (en) * 1997-11-24 1999-06-03 Novo Nordisk A/S PECTIN DEGRADING ENZYMES FROM $i(BACILLUS LICHENIFORMIS)
US6187580B1 (en) 1997-11-24 2001-02-13 Novo Nordisk A/S Pectate lyases
EP1187925B1 (en) * 1999-06-02 2005-03-30 Novozymes A/S Pectate lyase fusion for expression and secretion of polypeptides
EP2379717B1 (en) 2008-12-19 2015-09-02 DuPont Nutrition Biosciences ApS Process for production of an enzyme product
TR201809053T4 (tr) 2012-08-16 2018-07-23 Bangladesh Jute Res Institute Macrophomina phaseolina'dan elde edilen pektin parçalama enzimleri ve bunların kullanımları.
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885249A (en) 1984-12-05 1989-12-05 Allelix, Inc. Aspergillus niger transformation system
AU606033B2 (en) 1985-04-15 1991-01-31 Dsm Ip Assets B.V. Promotors of filamentous fungi and use thereof
ES2063162T5 (es) * 1988-07-28 2002-11-16 Novartis Ag Nuevo sistema de expresion.

Also Published As

Publication number Publication date
ZA88757B (en) 1988-08-04
IE880292L (en) 1988-08-04
GB8702475D0 (en) 1987-03-11
FI105484B (fi) 2000-08-31
ES2082746T5 (es) 2003-06-16
PT86684A (pt) 1988-03-01
MX10286A (es) 1993-12-01
CA1327330C (en) 1994-03-01
NO179078B (no) 1996-04-22
EP0278355B2 (en) 2002-10-23
PH26106A (en) 1992-02-06
DE3854947T3 (de) 2003-04-30
NO880470L (no) 1988-08-05
DK175569B1 (da) 2004-12-13
DK54588A (da) 1988-08-05
PT86684B (pt) 1992-04-30
KR970001116B1 (en) 1997-01-28
DE3854947T2 (de) 1996-11-14
DK54588D0 (da) 1988-02-03
IL85293A (en) 1992-12-01
JPS63273480A (ja) 1988-11-10
FI880439A (fi) 1988-08-05
KR880010126A (ko) 1988-10-07
GR3018863T3 (en) 1996-05-31
HU214005B (hu) 1998-08-28
JP2633885B2 (ja) 1997-07-23
DE3854947D1 (de) 1996-03-14
NO880470D0 (no) 1988-02-03
DD283838A5 (de) 1990-10-24
AU625773B2 (en) 1992-07-16
EP0683228A2 (en) 1995-11-22
IL85293A0 (en) 1988-07-31
HUT46357A (en) 1988-10-28
AU1123488A (en) 1988-08-18
DD283837A5 (de) 1990-10-24
EP0278355A2 (en) 1988-08-17
IE960902L (en) 1988-08-04
FI880439A0 (fi) 1988-02-01
DD267511A5 (de) 1989-05-03
EP0278355A3 (en) 1989-12-20
EP0683228A3 (en) 1996-03-06
NZ223392A (en) 1991-05-28
NO179078C (no) 1996-07-31
EP0278355B1 (en) 1996-01-31
ATE133706T1 (de) 1996-02-15
IE72506B1 (en) 1997-04-23
YU21688A (en) 1991-04-30

Similar Documents

Publication Publication Date Title
ES2082746T5 (es) Nuevo sistema de expresion.
EP0672131A4 (en) INTERACTION TRAP SYSTEM FOR ISOLATION OF NEW PROTEINS.
ES557840A0 (es) Metodo para obtener un vector de transferencia de bacteriofago recombinante
DE69433690D1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
DK443288A (da) Ekspressionskontrolsekvenser
DK0434605T3 (da) Ny fremgangsmåde til fremstilling af ikke-fusioneret protein i E.coli
EP0094797A3 (en) Novel cloning vehicles for polypeptide expression in microbial hosts
CA2024487A1 (en) Polygalacturonase encoding fungal expression system
WO1990007000A3 (en) Nucleotides encoding human b1, 4-galactosyltransferase and uses thereof
ES2079468T3 (es) Nuevo sistema de expresion fungico.
SE8100241L (sv) Mikrobiologiskt framstelld polypeptid med samma aminosyrasekvens som hos proinsulinet av primater, dna och plasmider, vilka kodierar for denna sekvens mikroorganismer, som innehaller dessa genetiska informationer, ...
WO2008016276A1 (en) Transmembrane delivery peptide and bio-material comprising the same
KR930013111A (ko) 바실러스의 파라-니트로벤질 에스테라제를 암호화하는 재조합 dna 화합물 및 발현벡터
WO1992014818A3 (en) Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences
Graham et al. Correlation of the genetic map and the endonuclease site map of Bacillus subtilis bacteriophage SP02
WO2000075362A3 (en) Method for identifying novel transcriptional regulatory proteins
Akins Characterization of Borrelia burgdorferi membrane proteins identified as PhoA-gene fusions.
McCarthy et al. Expression in vivo and in vitro of genes of the Escherichia coli unc operon.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 278355

Country of ref document: ES